Panel Discussion – The Current Landscape of Dry AMD Therapeutics

Time: 8:00 am
day: Day One


  • Reviewing complement inhibition as a means of treating dry AMD
  • Outlining the promise of small molecule, cell therapy, stem cell therapy and gene therapy
  • What is the earliest stage of AMD feasible for a clinical trial?